TimesSquare Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,710,926
| Closed | -$21.7M | – | 147 |
|
|
2024
Q4 | $21.7M | Sell |
1,710,926
-116,769
| -6% | -$1.48M | 0.32% | 115 |
|
|
2024
Q3 | $25.5M | Buy |
1,827,695
+139,160
| +8% | +$1.94M | 0.38% | 104 |
|
|
2024
Q2 | $23.3M | Buy |
1,688,535
+53,390
| +3% | +$736K | 0.37% | 105 |
|
|
2024
Q1 | $27M | Sell |
1,635,145
-30,920
| -2% | -$511K | 0.39% | 99 |
|
|
2023
Q4 | $24.3M | Buy |
1,666,065
+523,455
| +46% | +$7.64M | 0.36% | 102 |
|
|
2023
Q3 | $14M | Buy |
1,142,610
+336,910
| +42% | +$4.13M | 0.22% | 133 |
|
|
2023
Q2 | $9.62M | Buy |
+805,700
| New | +$9.62M | 0.14% | 147 |
|